Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embla Medical hfOSSFF 92 Forward Rate of Return (Yacktman) % is 14.28% as of Jun. 2026, which is 41% below its 10-year median of 24.25. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.15. The stock has 1 warning sign investors should review. Among 375 Medical Devices & Instruments companies, Embla Medical hf ranks better than 66.67% on this metric.
Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Embla Medical hf's forward rate of return for was 14.28%.
The historical rank and industry rank for Embla Medical hf's Forward Rate of Return (Yacktman) % or its related term are showing as below:
OSSFF'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 14.18 Med: 24.25 Max: 38.82
Current: 14.18
During the past 13 years, Embla Medical hf's highest Forward Rate of Return was 38.82. The lowest was 14.18. And the median was 24.25.
OSSFF's Forward Rate of Return (Yacktman) % is ranked better than 66.67% of 375
companies
in the Medical Devices & Instruments industry
Industry Median: 8.77
vs OSSFF: 14.18
Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Embla Medical hf (OTCPK:OSSFF) Forward Rate of Return (Yacktman) % Explanation
Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.
Be Aware
In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.
Embla Medical hf Forward Rate of Return (Yacktman) % Related Terms
Embla Medical hf Forward Rate of Return (Yacktman) % Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Forward Rate of Return (Yacktman) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf Forward Rate of Return (Yacktman) % Chart
OSSFF vs ABT, SYK, MDT: Forward Rate of Return (Yacktman) % Comparison
For the Medical Devices subindustry, Embla Medical hf's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Forward Rate of Return (Yacktman) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Forward Rate of Return (Yacktman) % distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Forward Rate of Return (Yacktman) % falls into.
Embla Medical hf Forward Rate of Return (Yacktman) % Calculation
Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Rate of Return (Yacktman) % of 14.28% mean?
Embla Medical hf (OSSFF) has a Forward Rate of Return (Yacktman) % of 14.28% as of Jun. 2026. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Embla Medical hf and its competitors. This is 41% below median its historical median of 24.25. Over the past decade, Embla Medical hf's Forward Rate of Return (Yacktman) % has ranged from 14.18 to 38.82. According to the industry distribution chart, Embla Medical hf ranks #125 out of 375 companies in the Medical Devices & Instruments industry, placing it in the top 33.3%.
Is Embla Medical hf's Forward Rate of Return (Yacktman) % too high?
Embla Medical hf's current Forward Rate of Return (Yacktman) % of 14.28% is 41% below median its 10-year median of 24.25. Over the past 10 years, this metric has ranged from a low of 14.18 to a high of 38.82. The Medical Devices & Instruments industry median Forward Rate of Return (Yacktman) % is 8.77. Embla Medical hf's value of 14.28% is 62.8% above this industry median. Based on the distribution chart, Embla Medical hf ranks #125 out of 375 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Forward Rate of Return (Yacktman) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #125 out of 375 companies for Forward Rate of Return (Yacktman) %. This puts Embla Medical hf in the upper half of its industry. The industry median Forward Rate of Return (Yacktman) % is 8.77. Embla Medical hf's value of 14.28% is 62.8% above this benchmark. Historically, Embla Medical hf's own Forward Rate of Return (Yacktman) % has ranged from 14.18 to 38.82 over the past decade. While the company's 10-year median is 24.25 vs. the industry median of 8.77, Embla Medical hf has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Rate of Return (Yacktman) % for a Medical Devices & Instruments company?
The median Forward Rate of Return (Yacktman) % among Medical Devices & Instruments companies is 8.77, based on 375 companies in the industry. Companies in the top quartile (top 25%) have a Forward Rate of Return (Yacktman) % significantly above this median, while those in the bottom quartile fall well below. However, Forward Rate of Return (Yacktman) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Forward Rate of Return (Yacktman) % of 14.28% is 62.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Rate of Return (Yacktman) % mean?
A high Forward Rate of Return (Yacktman) % can signal that a stock is expensive relative to its fundamentals. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Forward Rate of Return (Yacktman) % is 8.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Forward Rate of Return (Yacktman) % is 14.28%, which is 41% below median its own 10-year median of 24.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Forward Rate of Return (Yacktman) % of 14.28%. The stock's GF Value™ is $5.15, compared to a current price of $4.15 — trading 19.4% below its estimated fair value. The current Forward Rate of Return (Yacktman) % is 14.28%, which is 41% below median its 10-year median of 24.25 and 62.8% above the Medical Devices & Instruments industry median of 8.77. Embla Medical hf's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Rate of Return (Yacktman) % calculated?
Forward Rate of Return (Yacktman) % is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Forward Rate of Return (Yacktman) % is 14.28% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 19.4% below its estimated GF Value™ of $5.15.
Key valuation signals for OSSFF:
Forward Rate of Return (Yacktman) %: 14.28% (41% below median its 10-year median of 24.25)
GF Value™: $5.15 vs. price of $4.15 (19.4% below fair value)
Industry Position: 62.8% above the Medical Devices & Instruments median (#125 of 375)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
Forward Rate of Return (Yacktman) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
